Menu

CAR T-cell Therapy and Bispecific Antibodies: Frontiers in Cancer Immunotherapy

Get up to speed on the latest thinking in immune system-powered therapies. Bring your questions and comments for our esteemed speakers.

Feb 13, 2018
The Scientist Creative Services Team

Car T-Cell Therapy and Bispecific Antibodies: Frontiers in Cancer Immunology from thescientistllc on Vimeo.


Cancers are the most heterogenous group of diseases affecting humans. Multiple compensating pathways work to promote disease progression. Various immunotherapies have shown anticancer promise, but the their targeted nature limits the scope of their action and applicability. CAR T-cell therapy and bispecific antibodies are two approaches that have addressed the targeting of more than one epitope, the re-directing of T lymphocytes to kill tumor cells, and the improvement of efficacy in solid tumor types. For a closer look at the design, development, and success of CAR T-cell therapy and bispecific antibodies, The Scientist is bringing together a panel of experts to discuss their research and share insights into the potential these therapeutics hold in the fight against various tumor types. Join us to get your questions answered by our esteemed panel.

Topics to be covered:

  • Where cancer immunotherapies are living up to their promise, and where they’re falling short
  • The art and science of developing novel immunotherapies

Meet the Speakers:

Bruce Levine, PhD
Netter Professor in Cancer Gene Therapy
Founding Director, Clinical Cell and Vaccine Production Facility
Center for Cellular Immunotherapies Deputy Director
   – Technology Innovation and Assessment
Department of Pathology and Laboratory Medicine
Perelman School of Medicine, Abramson Cancer Center
                           University of Pennsylvania

 

John H. Sampson, MD, PhD, MBA, MHSc
Robert H. and Gloria Wilkins Professor of Neurosurgery
Chair, Department of Neurosurgery
Duke University Medical Center

 


September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!